Form 144/A - Report of proposed sale of securities: [Amend]
SEC Accession No. 0000950170-24-076972
Filing Date
2024-06-24
Accepted
2024-06-24 19:04:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144/A  
1 primary_doc.xml 144/A 3012
  Complete submission text file 0000950170-24-076972.txt   4600
Mailing Address C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY MA 94063
Business Address
Lewicki John A. (Reporting) CIK: 0001553352 (see all company filings)

Type: 144/A

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Subject) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 144/A | Act: 33 | File No.: 001-38452 | Film No.: 241065839
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)